These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 38157660

  • 1. Investigating Lycotoxin-An1a (An1a), a defense antiviral peptide from Alopecosa nagpag venom as prospective anti-dengue agent against DENV-2 NS2B-NS3 protease.
    Purohit P, Barik D, Dansana J, Meher BR.
    Comput Biol Chem; 2024 Feb; 108():108005. PubMed ID: 38157660
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Targeting the DENV NS2B-NS3 protease with active antiviral phytocompounds: structure-based virtual screening, molecular docking and molecular dynamics simulation studies.
    Purohit P, Sahoo S, Panda M, Sahoo PS, Meher BR.
    J Mol Model; 2022 Oct 24; 28(11):365. PubMed ID: 36274116
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Discovery of novel cyclic peptide inhibitors of dengue virus NS2B-NS3 protease with antiviral activity.
    Takagi Y, Matsui K, Nobori H, Maeda H, Sato A, Kurosu T, Orba Y, Sawa H, Hattori K, Higashino K, Numata Y, Yoshida Y.
    Bioorg Med Chem Lett; 2017 Aug 01; 27(15):3586-3590. PubMed ID: 28539222
    [Abstract] [Full Text] [Related]

  • 7. Discovery of antiviral molecules for dengue: In silico search and biological evaluation.
    Cabarcas-Montalvo M, Maldonado-Rojas W, Montes-Grajales D, Bertel-Sevilla A, Wagner-Döbler I, Sztajer H, Reck M, Flechas-Alarcon M, Ocazionez R, Olivero-Verbel J.
    Eur J Med Chem; 2016 Mar 03; 110():87-97. PubMed ID: 26807547
    [Abstract] [Full Text] [Related]

  • 8. 3D-QSAR and molecular docking studies of peptide-hybrids as dengue virus NS2B/NS3 protease inhibitors.
    Jitonnom J, Meelua W, Tue-Nguen P, Saparpakorn P, Hannongbua S, Chotpatiwetchkul W.
    Chem Biol Interact; 2024 Jun 01; 396():111040. PubMed ID: 38735453
    [Abstract] [Full Text] [Related]

  • 9. Recent advances in natural products as potential inhibitors of dengue virus with a special emphasis on NS2b/NS3 protease.
    Saqallah FG, Abbas MA, Wahab HA.
    Phytochemistry; 2022 Oct 01; 202():113362. PubMed ID: 35948138
    [Abstract] [Full Text] [Related]

  • 10. Structure activity relationship (SAR) and quantitative structure activity relationship (QSAR) studies showed plant flavonoids as potential inhibitors of dengue NS2B-NS3 protease.
    Sarwar MW, Riaz A, Dilshad SMR, Al-Qahtani A, Nawaz-Ul-Rehman MS, Mubin M.
    BMC Struct Biol; 2018 Apr 19; 18(1):6. PubMed ID: 29673347
    [Abstract] [Full Text] [Related]

  • 11. Design and docking studies of peptide inhibitors as potential antiviral drugs for dengue virus ns2b/ns3 protease.
    Velmurugan D, Mythily U, Rao K.
    Protein Pept Lett; 2014 Apr 19; 21(8):815-27. PubMed ID: 23855663
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Identification of novel and potential inhibitors against the dengue virus NS2B/NS3 protease using virtual screening and biomolecular simulations.
    Nasir A, Samad A, Ajmal A, Li P, Islam M, Ullah S, Shah M, Bai Q.
    Int J Biol Macromol; 2024 Jun 19; 272(Pt 1):132855. PubMed ID: 38834129
    [Abstract] [Full Text] [Related]

  • 14. Exploring the antiviral inhibitory activity of Niloticin against the NS2B/NS3 protease of Dengue virus (DENV2).
    Stalin A, Han J, Daniel Reegan A, Ignacimuthu S, Liu S, Yao X, Zou Q.
    Int J Biol Macromol; 2024 Oct 19; 277(Pt 1):133791. PubMed ID: 38992553
    [Abstract] [Full Text] [Related]

  • 15. Dengue Virus NS2B/NS3 Protease Inhibitors Exploiting the Prime Side.
    Lin KH, Ali A, Rusere L, Soumana DI, Kurt Yilmaz N, Schiffer CA.
    J Virol; 2017 May 15; 91(10):. PubMed ID: 28298600
    [Abstract] [Full Text] [Related]

  • 16. Allosteric pocket of the dengue virus (serotype 2) NS2B/NS3 protease: In silico ligand screening and molecular dynamics studies of inhibition.
    Mukhametov A, Newhouse EI, Aziz NA, Saito JA, Alam M.
    J Mol Graph Model; 2014 Jul 15; 52():103-13. PubMed ID: 25023665
    [Abstract] [Full Text] [Related]

  • 17. Exploring allosteric hits of the NS2B-NS3 protease of DENV2 by structure-guided screening.
    Gangopadhyay A, Saha A.
    Comput Biol Chem; 2023 Jun 15; 104():107876. PubMed ID: 37141792
    [Abstract] [Full Text] [Related]

  • 18. Exploiting the unique features of Zika and Dengue proteases for inhibitor design.
    Majerová T, Novotný P, Krýsová E, Konvalinka J.
    Biochimie; 2019 Nov 15; 166():132-141. PubMed ID: 31077760
    [Abstract] [Full Text] [Related]

  • 19. Lead Optimization Studies Towards Finding NS2B/NS3 Protease Targetspecific Inhibitors as Potential Anti-dengue Drug-like Compounds.
    Gurusamy M, Abdul JF.
    Curr Drug Discov Technol; 2019 Nov 15; 16(3):307-314. PubMed ID: 29984660
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.